Events2Join

Bio|Path Holdings Inc. filed SEC Form 8|K


SEC Filings - ImmunityBio, Inc.

Filing Group, View. Nov 12, 2024, 10-Q. Quarterly report which ... 8-K. Report of unscheduled material events or corporate event.

united states securities and exchange commission - form 8-k

ORGANOVO HOLDINGS, INC. (Exact name of registrant as specified in its charter). Commission File Number: 001-35996. Delaware. 27-1488943. (State ...

SEC Filing - Investor Overview - Invivyd

a biotechnology company. Mr. Heyman previously served as the President of Johnson & Johnson's Corporate Venture Capital Group, the venture capital arm of ...

Small Entity Compliance Guide - FinCEN

section 2 of the Bank Holding Company Act of 1956. (12 U.S.C. 1841). □ Yes ... form) filed with the Securities and Exchange. Commission or will be so ...

Bio-Path Holdings Reports Third Quarter 2024 Financial Results

Expands DNAbilize® Technology Beyond Oncology into Obesity Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Nov.

SEC Filings - Regenxbio Inc

Filing Group, View. Nov 12, 2024, SC 13G/A. An amendment to the SC 13G ... 8-K. Report of unscheduled material events or corporate event. Current Reports.

SEC Filings | Adicet Bio

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML · 10-K. Annual report which provides a comprehensive overview of the company for the past year. Mar 12, 2020.

SEC Filings - BioXcel Therapeutics

8-K. Report of unscheduled material events or corporate event. Nov 14, 2024 ... Copyright © 2024 BioXcel Therapeutics, Inc. All Rights Reserved. Privacy ...

SEC Filings - BridgeBio

Filing date · Description · Form, View. 11.12.2024. Report of unscheduled material events or corporate event. 8-K · 0000950170-24-124576.

Ginkgo Bioworks Holdings, Inc. (Form: 8-K, Received - EDGAR Online

The Company's Class A common stock and public warrants are deemed to be registered under Section 12(b) of the Exchange Act, and the Company will hereafter file ...

Bio-Path Holdings Reports Third Quarter 2024 Financial Results

Expands DNAbilize® Technology Beyond Oncology into Obesity. Conference Call to be Held Today at 8:30 A.M. ET. HOUSTON, Nov.

Financials & Filings | Climb Bio

SEC Filings ; Apr 29, 2024. Amendment to a previously filed 10-K · 10-K/A ; Mar 07, 2022. Annual report which provides a comprehensive overview of the company for ...

VBHI / Verde Bio Holdings, Inc. - SEC Filings, Annual Report ... - Fintel

Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. 2020-02-12, 8-K. Entry into a Material Definitive Agreement, ...

SEC Filings - Day One Biopharmaceuticals, Inc.

Oct 31, 2024. Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144 ; Oct 30, 2024. Report of unscheduled ...

Form 8-K for Fortrea Holdings INC filed 11/29/2023

Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class Trading Symbol Name of exchange on which registered.

Financials & Filings - 89bio, Inc.

SEC Filings. Group. All Filings, 3,4,5, Annual Filings, Current ... Amendment to a previously filed 8-K. Current Reports. 0001193125-24 ...

SEC Filings - Investor Relations | PROCEPT BioRobotics Corp

Nov 4, 2024. An amendment to the SC 13G filing. SC 13G/A ; Oct 31, 2024. Report of unscheduled material events or corporate event. 8-K ; Oct ...

Tevogen Bio Holdings Inc. Common Stock (TVGN) SEC Filings

Find the latest SEC Filings data for Tevogen Bio Holdings Inc. Common Stock (TVGN) including 10-K and 10-Q forms at Nasdaq ... 8-K, 08/23/2024, 08/20/2024. HTML ...

Download Forms / Online Filing Instructions | WA Secretary of State

K-12 & CollegeOpen submenu ... The following filings are specific to the business entity type. Profit Corporation, Filing Fees, Mail-In Forms, Online Filing ...

Financials & Filings - BioCardia

XBRL viewer for form 8-K filed on Nov 13, 2024. Nov 13, 2024, 10-Q · Quarterly ... BioCardia®, CardiAMP™, CardiALLO™, Helix™, and Morph® are trademarks of ...